Journals / Medeniyet Medical Journal / 2019 / Cilt: 34 - Sayı: 4

Effects of Bispectral Index-controlled Use of Magnesium on Propofol Consumption and Sedation Level in Patients Undergoing Colonoscopy

Pages
380–386
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No significant difference was found between the groups in terms of patient- and endoscopist-satisfaction (p<0.05).Conclusion: The use of magnesium in addition to propofol may be an efficient and reliable op-tion to reduce the drug consumption during colonoscopic interventions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to investigate the effects of bispectral index-controlled use of magnesium on propofol consumption, periprocedural hemodynamic response and patient comfort.Material: A total of 60 patients were enrolled in the study.
📊
Key Findings & Data:In Group 1 (magnesium), a single dose 50 mg/kg magnesium sulfate diluted with 100 mL 0.9% NaCl was administered 10 min-utes before the beginning of the procedure.
💡
Conclusion & Impact:No significant difference was found between the groups in terms of patient- and endoscopist-satisfaction (p<0.05).Conclusion: The use of magnesium in addition to propofol may be an efficient and reliable op-tion to reduce the drug consumption during colonoscopic interventions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The aim of this study is to investigate the effects of bispectral index-controlled use of magnesium on propofol consumption, periprocedural hemodynamic response and patient comfort.Material: A total of 60 patients were enrolled in the study. In Group 1 (magnesium), a single dose 50 mg/kg magnesium sulfate diluted with 100 mL 0.9% NaCl was administered 10 min-utes before the beginning of the procedure. Initially bolus dose of 0.5 mg/kg propofol was ap-plied. The maintenance dose of propofol was 60 mcg/kg/min. During the procedure, the propo-fol infusion was increased by titration until the bispectral index (BIS) value of 70 was achieved. In Group 2 (saline), 100 ml 0.9% NaCl was administered 10 minutes before the beginning of the procedure. The bolus and maintenance doses of propofol, and target BIS values were the same as those in Group 1.Results: When BIS values were compared between the groups, the initial BIS values in the magnesium group (Group 1) were significantly higher than those of the saline group (Group 2) (p<0.05). The time to reach BIS 70 was significantly shorter in the magnesium group (p<0.05). Propofol consumption was greater in Group 2 than in Group 1 (p<0.05). The time to reach BIS 70 was significantly shorter in Group 1 (p<0.05). No significant difference was found between the groups in terms of patient- and endoscopist-satisfaction (p<0.05).Conclusion: The use of magnesium in addition to propofol may be an efficient and reliable op-tion to reduce the drug consumption during colonoscopic interventions.

🔖

Cite This Article

YOLDAŞ, H., YILDIZ, I., KARAGOZ, I., DEMIRHAN, A., BİLGİ, M., SIT, M., OGUN, M. N. (2019). Effects of Bispectral Index-controlled Use of Magnesium on Propofol Consumption and Sedation Level in Patients Undergoing Colonoscopy. Medeniyet Medical Journal, Cilt: 34 - Sayı: 4, 380–386. https://ajindex.com/articles/283276

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Shingina A, Ou G, Takach O, et al. Identification of fac-tors associated with sedation tolerance in 5000 pa-tients undergoing outpatient colonoscopy: Canadian tertiary center experience. World J Gastrointest Endosc. 2016;8(20):770-776. [CrossRef] 2. Demiraran Y, Tamer A, Korkut E, et al. Comparison of the sedative effects of dexmedetomidine and midazolam in cases undergoing colonoscopy. Endoskopy. 2009;17:18-22. 3. Kilgert B, Rybizki L, Grottke M, Neurath MF, Neumann H. Prospective long-term assessment of sedation-related ad-verse events and patient satisfaction for upper endoscopy and colonoscopy. Digestion. 2014;90:42-8. [CrossRef] 4. Sonnenberg A. Sedation in Colonoscopy. Gastroenterol Hepatol (N Y). 2016;12:327-9. 5. Regula J, Sokol-Kobielska E. Sedation in endoscopy: when and how. Best Pract Res Clin Gastroenterol. 2008;22(5):945-57. [CrossRef] 6. Toklu S, Iyilikci L, Gonen C, et al. Comparison of etomi-date-remifentanil and propofol-remifentanil sedation in patients scheduled for colonoscopy. Eur J Anaesthesiol. 2009;26:370-6. [CrossRef] 7. Yu YH, Han DS, Kim HS, et al. Efficacy of bispectral in-dex monitoring during balanced propofol sedation for colonoscopy: a prospective, randomized controlled trial. Dig Dis Sci. 2013;58:3576-83. [CrossRef] 8. Odom MJ, Zuckerman SL, Mocco J. The role of magne-sium in the management of cerebral vasospasm. Neurol Res Int. 2013;2013:943914. [CrossRef] 9. Altan A, Turgut N, Yildiz F, Türkmen A, Ustün H. Effects of magnesium sulphate and clonidine on propofol con-sumption, haemodynamics and postoperative recovery. Br J Anaesth. 2005;94:438-41. [CrossRef] 10. Amer MM, Abdelaal Ahmed Mahmoud A, Abdelrahman Mohammed MK, Elsharawy AM, Ahmed DA, Farag EM. Effect of magnesium sulphate on bi-spectral index (BIS)values during general anesthesia in children. BMC Anes-thesiol. 2015;15:126. [CrossRef] 11. Inadomi JM, Gunnarsson CL, Rizzo JA, Fang H. Projected increased growth rate of anesthesia professional-delivered sedation for colonoscopy and EGD in the United States: 2009 to 2015. Gastrointest Endosc. 2010;72:580-6. [CrossRef] 12. Bilgi M, Tekelioglu UY, Sit M, et al. Comparison of the effects of bispectral index-controlled use of remifenta-nil on propofol consumption and patient comfort in pa-tients undergoing colonoscopy. Acta Gastroenterol Belg. 2015;78:314-8. 13. Sieg A; bng-Study-Group, Beck S, Scholl SG, et al. Safety analysis of endoscopist-directed propofol sedation: a prospective, national multicenter study of 24